Scinovex
article Open Access

Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer

British Journal of Cancer · 2003 · Vol. 89(6) · pp. 1028–1030
L M ForrestDonald C. McMillanC S McArdleWilson J. AngersonDavid J. Dunlop

Abstract

A score based on the combination of the systemic inflammatory response and albumin hazards ratio (HR) 1.70, 95% CI 1.23 - 2.35, P=0.001) was comparable in prognostic value to that based on stage and performance status (HR 1.48, 95% CI 1.12 - 1.95, P=0.006) in patients with inoperable non-small-cell lung cancer. The former is simple to measure and well standardised.

Inflammatory Biomarkers in Disease PrognosisVenous Thromboembolism Diagnosis and ManagementCancer Immunotherapy and BiomarkersMedicineInternal medicineOncologyLung cancerProportional hazards modelStage (stratigraphy)CancerGastroenterology

MeSH terms

AdenocarcinomaAlbuminsC-Reactive ProteinCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellFemaleHumansInflammationLung NeoplasmsMaleMiddle AgedNeoplasm StagingPrognosisProspective StudiesRetrospective Studies
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.